Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningMelphalanGranulocyte Colony-Stimulating FactorCombined Modality TherapyHematologic NeoplasmsLeukapheresisAntigens, CD34Blood Component RemovalStem Cell TransplantationGraft vs Host DiseaseCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsBusulfanMyeloablative AgonistsGraft SurvivalTreatment OutcomeLymphoma, Non-HodgkinHematopoietic Stem CellsEtoposideRemission InductionThiotepaRecurrenceAntineoplastic Agents, AlkylatingCarmustineCytophagocytosisTransplantation ChimeraSalvage TherapyIfosfamideHematopoiesisTissue DonorsVincristineWhole-Body IrradiationCytarabineCord Blood Stem Cell TransplantationAmyloidosisStem CellsHodgkin DiseaseDisease-Free SurvivalRetrospective StudiesBone MarrowSurvival RateHistocompatibilityNeoplasmsTime FactorsSurvival AnalysisHistocompatibility TestingLiver TransplantationInfectionTransplantation, IsogeneicImmunosuppressive AgentsLeukemiaLymphoma, T-CellLeukemia, Myeloid, AcuteDoxorubicinPlatelet CountBone Marrow PurgingPOEMS SyndromePrednisoneBone Marrow CellsAnemia, AplasticFollow-Up StudiesCarboplatinVidarabineBlood Cell CountDexamethasoneCytomegalovirus InfectionsRecombinant ProteinsLymphomaGraft vs Leukemia EffectKidney TransplantationProspective StudiesFatal OutcomeBlood CellsAntineoplastic AgentsMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFeasibility StudiesLymphocyte DepletionImmunophenotypingPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressionT-LymphocytesHLA AntigensCyclosporineHematologic DiseasesTransplantation ImmunologyOpportunistic InfectionsBone Marrow DiseasesPrognosisBlood Transfusion, AutologousHistiocytosis, Non-Langerhans-CellCell TransplantationMesenchymal Stem Cell Transplantation